Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Puma Biotechnology (PBYI) Current Assets (2017 - 2025)

Historic Current Assets for Puma Biotechnology (PBYI) over the last 9 years, with Q3 2025 value amounting to $143.6 million.

  • Puma Biotechnology's Current Assets fell 844.1% to $143.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $143.6 million, marking a year-over-year decrease of 844.1%. This contributed to the annual value of $147.7 million for FY2024, which is 545.96% down from last year.
  • Per Puma Biotechnology's latest filing, its Current Assets stood at $143.6 million for Q3 2025, which was down 844.1% from $136.6 million recorded in Q2 2025.
  • Puma Biotechnology's 5-year Current Assets high stood at $167.8 million for Q2 2021, and its period low was $111.8 million during Q1 2023.
  • Moreover, its 5-year median value for Current Assets was $136.9 million (2021), whereas its average is $137.2 million.
  • Its Current Assets has fluctuated over the past 5 years, first crashed by 3187.52% in 2022, then surged by 2798.4% in 2024.
  • Over the past 5 years, Puma Biotechnology's Current Assets (Quarter) stood at $140.0 million in 2021, then decreased by 4.1% to $134.3 million in 2022, then grew by 16.31% to $156.2 million in 2023, then fell by 5.46% to $147.7 million in 2024, then decreased by 2.76% to $143.6 million in 2025.
  • Its Current Assets was $143.6 million in Q3 2025, compared to $136.6 million in Q2 2025 and $132.5 million in Q1 2025.